Kalvista Pharmaceuticals Inc (KALV.OQ)
KALV.OQ on NASDAQ Stock Exchange Global Market
12.70USD
14 Aug 2020
12.70USD
14 Aug 2020
Change (% chg)
$0.25 (+2.05%)
$0.25 (+2.05%)
Prev Close
$12.44
$12.44
Open
$12.26
$12.26
Day's High
$12.81
$12.81
Day's Low
$12.00
$12.00
Volume
16,370
16,370
Avg. Vol
45,477
45,477
52-wk High
$18.87
$18.87
52-wk Low
$5.65
$5.65
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2020 | Apr '20 | 3.82 | -0.369 |
| Jan '20 | 1.58 | -0.521 | |
| Oct | 3.92 | -0.331 | |
| Jul | 3.37 | -0.420 | |
| FY 2019 | Apr '19 | 2.93 | -0.496 |
| Jan '19 | 3.89 | -0.230 | |
| Oct | 5.59 | -0.219 | |
| Jul | 3.72 | -0.466 | |
| FY 2018 | Apr '18 | 4.84 | -0.061 |
| Jan '18 | 2.33 | -0.485 | |
| Oct | 1.13 | -0.498 | |
| Jul | 0.10 | -0.507 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jan-20 | 5 | 11.42 | 43.10 | 3.00 | -- |
| Quarter Ending Apr-20 | 8 | 1.66 | 4.12 | 0.00 | -- |
| Year Ending Apr-20 | 8 | 10.54 | 12.98 | 8.87 | -- |
| Year Ending Apr-21 | 7 | 2.89 | 10.00 | 0.00 | 33.64 |
| Year Ending Apr-22 | 5 | 18.53 | 26.30 | 10.00 | 26.30 |
| Earnings (per share) | |||||
| Quarter Ending Jan-20 | 7 | -0.26 | 1.49 | -0.63 | -- |
| Quarter Ending Apr-20 | 8 | -0.65 | -0.54 | -0.80 | -- |
| Year Ending Apr-20 | 8 | -1.94 | -1.81 | -2.11 | -- |
| Year Ending Apr-21 | 7 | -2.68 | -2.21 | -3.68 | -2.18 |
| Year Ending Apr-22 | 5 | -2.79 | -1.59 | -4.24 | -0.87 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | -- | 35.05 | 43.39 | |
| P/E High - Last 5 Yrs. | -- | 43.38 | 46.43 | |
| P/E Low - Last 5 Yrs. | -- | 25.27 | 25.22 | |
| Beta | 2.38 | 0.96 | 0.94 | |
| Price to Sales (TTM) | 17.86 | 4.58 | 8.03 | |
| Price to Book (MRQ) | 2.71 | 4.23 | 4.59 | |
| Price to Tangible Book (MRQ) | 2.71 | 5.00 | 5.69 | |
| Price to Cash Flow (TTM) | -- | 21.53 | 28.96 | |
| % Owned Institutions | -- | 0.00 | 0.00 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | -- | 1.50 | 1.41 | |
| Dividend Yield - 5 Year Avg | -- | 0.91 | 0.91 | |
| Dividend 5 Year Growth Rate | -- | 3.89 | 4.70 | |
| Payout Ratio(TTM) | -- | 50.07 | 47.48 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 30.69 | 9.48 | 8.24 | |
| Sales (TTM) vs TTM 1 Yr. Ago | -21.31 | 13.33 | 12.62 | |
| Sales - 5 Yr. Growth Rate | -- | 5.88 | 6.13 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 25.63 | 82.59 | 68.52 | |
| EPS (TTM) vs TTM 1 Yr. Ago | -16.34 | -- | -- | |
| EPS - 5 Yr. Growth Rate | -- | 8.51 | 8.77 | |
| Capital Spending - 5 Yr. Growth Rate | -- | 13.04 | 12.95 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | -- | 2.33 | 2.35 |
| Current Ratio (MRQ) | 11.49 | 3.16 | 3.19 |
| LT Debt to Equity (MRQ) | 0.00 | 12.72 | 14.96 |
| Total Debt to Equity (MRQ) | 0.00 | 18.50 | 20.98 |
| Interest Coverage (TTM) | -- | 12.09 | 14.89 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | -- | 54.76 | 54.52 | |
| Gross Margin - 5 Yr. Avg. | -- | 54.67 | 54.25 | |
| EBITD Margin (TTM) | -315.38 | -- | -- | |
| EBITD - 5 Yr. Avg | -- | 19.11 | 12.69 | |
| Operating Margin (TTM) | -319.42 | 14.83 | -0.05 | |
| Operating Margin - 5 Yr. Avg. | -- | 14.82 | 7.81 | |
| Pre-Tax Margin (TTM) | -230.42 | 15.20 | -0.87 | |
| Pre-Tax Margin - 5 Yr. Avg. | -- | 15.11 | 7.99 | |
| Net Profit Margin (TTM) | -229.44 | 11.50 | -4.53 | |
| Net Profit Margin - 5 Yr. Avg. | -- | 11.44 | 4.42 | |
| Effective Tax Rate (TTM) | -- | 17.16 | 18.06 | |
| Effective Tax Rate - 5 Yr. Avg. | -- | 22.16 | 22.26 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 226,607 | 979,457,375 | 850,657,851 | |
| Net Income/Employee (TTM) | -519,929 | 112,361,214 | 97,470,409 | |
| Receivable Turnover (TTM) | 0.91 | 5.48 | 5.76 | |
| Inventory Turnover (TTM) | -- | 2.55 | 3.24 | |
| Asset Turnover (TTM) | 0.12 | 0.81 | 0.79 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | -27.64 | 10.42 | 9.87 | |
| Return on Assets - 5 Yr. Avg. | -- | 11.11 | 10.65 | |
| Return on Investment (TTM) | -31.50 | 13.00 | 12.38 | |
| Return on Investment - 5 Yr. Avg. | -- | 13.89 | 13.32 | |
| Return on Equity (TTM) | -32.26 | 14.70 | 14.20 | |
| Return on Equity - 5 Yr. Avg. | -- | 16.65 | 16.01 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | -21.31 | 103.58 | -- |
| EPS (TTM) % | -18.85 | -- | -- |
| Dividend % | -- | -- | -- |
Note: Units in Millions of US Dollars
Performance for Kalvista Pharmaceuticals Inc
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 0.61 | -4.10 | 45 | 79 |
| 13 Week | 28.43 | 8.60 | 67 | 36 |
| 26 Week | -17.14 | -17.13 | 26 | 81 |
| 52 Week | -22.94 | -35.11 | 28 | 72 |
| YTD | -30.12 | -33.08 | 18 | 74 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 94.43% |
| # of Holders: | 121 |
| Total Shares Held: | 16,853,593 |
| 3 Mo. Net Change: | 144,234 |
| # New Positions: | 8 |
| # Closed Positions: | 7 |
| # Increased Positions: | 34 |
| # Reduced Positions: | 21 |
| # Net Buyers: | 13 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.